# A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219)

> **NCT01732458** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 229 (actual)

## Conditions studied

- Post-operative Nausea
- Post-operative Vomiting

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Placebo to Aprepitant
- **DRUG:** Ondansetron
- **DRUG:** Placebo to match ondansetron

## Key facts

- **NCT ID:** NCT01732458
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-12
- **Primary completion:** 2016-09-26
- **Final completion:** 2016-09-26
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2018-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01732458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01732458, "A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219)". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT01732458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*